Literature DB >> 7367112

Ventriculoperitoneal shunt-associated infection due to Haemophilus influenzae.

P A Patriarca, B A Lauer.   

Abstract

We report two children with ventriculoperitoneal shunt infections due to Haemophilus influenzae, type b. One child was cured with systemic and intraventricular antimicrobial therapy alone. The other child had persistently positive ventricular fluid cultures, ultimately required shunt removal in addition to antimicrobial therapy, and still had a relapse, which responded to antimicrobial therapy alone. In treating children with this problem we recommend removal of the shunt apparatus unless there is prompt sterilization of ventricular fluid and clinical improvement. Systemic antimicrobial therapy should be continued for two to four weeks.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7367112

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  5 in total

1.  Shunt malfunction in relation to shunt infection.

Authors:  V Vanaclocha; N Sáiz-Sapena; J Leiva
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

2.  Cerebrospinal fluid shunt infections by unencapsulated Haemophilus influenzae.

Authors:  L C Hellbusch; R G Penn
Journal:  Childs Nerv Syst       Date:  1989-10       Impact factor: 1.475

3.  Haemophilus influenzae meningitis in the presence of cerebrospinal fluid shunts.

Authors:  S Stern; R Bayston; R J Hayward
Journal:  Childs Nerv Syst       Date:  1988-06       Impact factor: 1.475

4.  Circulating immune complexes in infected ventriculoatrial and ventriculoperitoneal shunts.

Authors:  F P Schena; G Pertosa; A Pastore; A De Tommasi; M T Montagna; L Bonomo
Journal:  J Clin Immunol       Date:  1983-04       Impact factor: 8.317

5.  Characteristics of Intracranial Group A Streptococcal Infections in US Children, 1997-2014.

Authors:  Ruth Link-Gelles; Karrie-Ann Toews; William Schaffner; Kathryn M Edwards; Carolyn Wright; Bernard Beall; Brenda Barnes; Brenda Jewell; Lee H Harrison; Pam D Kirley; Lauren Lorentzson; Deborah Aragon; Susan Petit; Joseph Bareta; Nancy L Spina; Paul R Cieslak; Chris Van Beneden
Journal:  J Pediatric Infect Dis Soc       Date:  2020-02-28       Impact factor: 3.164

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.